CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,277,000 | -11.1% | 49,810 | -17.6% | 0.08% | +13.0% |
| Q2 2022 | $1,437,000 | -46.0% | 60,418 | -48.8% | 0.07% | -53.7% |
| Q1 2022 | $2,659,000 | +3.4% | 118,063 | -9.1% | 0.15% | +55.2% |
| Q4 2021 | $2,571,000 | +29.0% | 129,857 | +28.2% | 0.10% | -6.8% |
| Q3 2021 | $1,993,000 | +143.3% | 101,295 | +172.0% | 0.10% | +194.3% |
| Q2 2021 | $819,000 | -52.5% | 37,247 | -48.6% | 0.04% | -63.5% |
| Q1 2021 | $1,725,000 | +175.1% | 72,495 | +94.4% | 0.10% | -7.7% |
| Q2 2020 | $627,000 | +69.5% | 37,295 | +21.9% | 0.10% | +246.7% |
| Q4 2019 | $370,000 | -69.9% | 30,600 | -64.9% | 0.03% | -60.0% |
| Q3 2019 | $1,231,000 | +281.1% | 87,100 | +200.3% | 0.08% | +167.9% |
| Q2 2019 | $323,000 | -60.9% | 29,000 | -58.8% | 0.03% | -77.6% |
| Q1 2019 | $826,000 | +216.5% | 70,400 | +261.0% | 0.12% | +62.3% |
| Q4 2018 | $261,000 | – | 19,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |